Serial 98206529
Live / Allowed — Notice of allowance issued (as of 29 Apr 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Oct 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98206529
- Mark type
- Design / logo
- Filed
- 02 Oct 2023
- Published for opposition
- 04 Mar 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for human use for the treatment of adrenal insufficiency; pharmaceutical preparations for human use for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 27 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Mar 2025 — PUBLISHED FOR OPPOSITION
- 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Aug 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 27 Aug 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 15 Aug 2024 — NOTIFICATION OF PRIORITY ACTION E-MAILED